🇺🇸 d-cycloserine in United States
8 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 8
Most-reported reactions
- Drug Resistance — 3 reports (37.5%)
- Pathogen Resistance — 2 reports (25%)
- Off Label Use — 1 report (12.5%)
- Pain In Extremity — 1 report (12.5%)
- Vomiting — 1 report (12.5%)
Other Psychiatry/Neurology approved in United States
Frequently asked questions
Is d-cycloserine approved in United States?
d-cycloserine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for d-cycloserine in United States?
Massachusetts General Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.